Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 951 - 975 of 2,711

«
1
…
37
38
39
40
41
…
109
»

What New in Hematopoietic Stem Cell Transplantation

What New in Hematopoietic Stem Cell Transplantation

By: Joseph M. Tuscano, MD

Acute Myeloid and Lymphoid Leukemias

Acute Myeloid and Lymphoid Leukemias

By: Kevin Kelly, MD, PhD

Diffuse Large Cell Lymphoma - The Latest and Greatest

Diffuse Large Cell Lymphoma - The Latest and Greatest

By: Leslie Popplewell, MD, FACP

How to Decide which Frontline Therapy in MM After First Relapse Post-Transplant

How to Decide which Frontline Therapy in MM After First Relapse Post-Transplant

By: Melissa Alsina, MD

By: Mohamed A. Kharfan-Dabaja, MD, MBA

Chimeric Antigen Receptor (CAR) T Cell Therapy - Progress and Challenges

Chimeric Antigen Receptor (CAR) T Cell Therapy - Progress and Challenges

By: Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

Management of Metastatic Breast Cancer

Management of Metastatic Breast Cancer

By: Noridza Rivera-Rodriguez, MD

Myelodysplasia and Secondary AML

Myelodysplasia and Secondary AML

By: Rami Komrokji, MD

Melanoma: Beyond Checkpoint Inhibitors

Melanoma: Beyond Checkpoint Inhibitors

By: Sanjiv S. Agarwala, MD

Multiple Myeloma Transplant and Non-transplant Modalities

Multiple Myeloma Transplant and Non-transplant Modalities

By: Sikander Ailawadhi, MD

Lymphoma: State of the Art

Lymphoma: State of the Art

By: Alexey Danilov, MD, PhD

Clinical Update: Malignant Hematology

Clinical Update: Malignant Hematology

By: Atis Barzdins, MD

DLBCL & Hodgkin’s Disease: Novel Approaches

DLBCL & Hodgkin’s Disease: Novel Approaches

By: Eduardo Sotomayor, MD

Hematology Session III

Hematology Session III

By: Francine Foss, Eduardo Sotomayor, Nakhle Saba

T-Cell NHL: What’s New?

T-Cell NHL: What’s New?

By: Francine M. Foss, MD

CLL: Novel Therapies

CLL: Novel Therapies

By: Javier Pinilla-Ibarz, MD

CAR-T Cell as Strategy for the Management of Hematologic Malignancies

CAR-T Cell as Strategy for the Management of Hematologic Malignancies

By: Krishna Komanduri, MD

Other Driver Mutations: cMET, B-RAF, RET, NTRK

Other Driver Mutations: cMET, B-RAF, RET, NTRK

By: Luis E. Raez, MD, FACP, FCCP

Current Status of CAR-T Therapy in Hematology

Current Status of CAR-T Therapy in Hematology

By: Matthew Matasar, MD

Current Status of CAR-T Therapy in Hematology

Current Status of CAR-T Therapy in Hematology

By: Matthew Matasar, MD

Lymphoma and CLL 2024 Updates

Lymphoma and CLL 2024 Updates

By: Maxwell M. Krem, MD, PhD

Updates on FL and CLL from the ASH 2021 Meeting

Updates on FL and CLL from the ASH 2021 Meeting

By: Mazyar Shadman, MD, MPH

Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges

Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges

By: Mohamed Kharfan-Dabaja, MD

AML and MDS: New Directions

AML and MDS: New Directions

By: Olatoyosi Odenike, MD

State of the Art Management of Sickle Cell Anemia

State of the Art Management of Sickle Cell Anemia

By: Oyebimpe Adesina, MD

«
1
…
37
38
39
40
41
…
109
»

Post navigation

← Previous View

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok